Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: HIV Med. 2015 Apr;16(0 1):30–36. doi: 10.1111/hiv.12231

Table 1. Demographics and Selected Other Characteristics, by Region.

Factor, N (%) or Median North
America
Europe South
America
Australia Asia Africa Overall
Participants 507 (10.8) 1539 (32.8) 1174 (25.1) 109 (2.3) 356 (7.6) 1000 (21.3) 4685
Demographics
Age, years 36 38 32 40 33 38 36
 < 25 78 (15.4) 93 (6.0) 200 (17.0) 3 (2.8) 61 (17.1) 65 (6.5) 500 (10.7)
 25-34 150 (29.6) 524 (34.0) 468 (39.9) 36 (33.0) 145 (40.7) 292 (29.2) 1615 (34.5)
 35-44 125 (24.7) 513 (33.3) 306 (26.1) 40 (36.7) 114 (32.0) 391 (39.1) 1489 (31.8)
 ≥ 45 154 (30.4) 409 (26.6) 200 (17.0) 30 (27.5) 36 (10.1) 252 (25.2) 1081 (23.1)
Female 111 (21.9) 140 (9.1) 175 (14.9) 4 (3.7) 136 (38.2) 691 (69.1) 1257 (26.8)
Race
 Black, male 172 (33.9) 51 (3.3) 107 (9.1) 2 (1.8) 0 (0.0) 286 (28.6) 618 (13.2)
 Black, female 68 (13.4) 46 (3.0) 26 (2.2) 1 (0.9) 0 (0.0) 651 (65.1) 792 (16.9)
 Latino, male 68 (13.4) 62 (4.0) 409 (34.8) 1 (0.9) 0 (0.0) 0 (0.0) 540 (11.5)
 Latina, female 23 (4.5) 7 (0.5) 69 (5.9) 0 (0.0) 0 (0.0) 0 (0.0) 99 (2.1)
 Asian, male 8 (1.6) 20 (1.3) 0 (0.0) 5 (4.6) 216 (60.7) 0 (0.0) 249 (5.3)
 Asian, female 1 (0.2) 2 (0.1) 0 (0.0) 0 (0.0) 136 (38.2) 0 (0.0) 139 (3.0)
 White, male 144 (28.4) 1241 (80.6) 401 (34.2) 93 (85.3) 2 (0.6) 13 (1.3) 1894 (40.4)
 White, female 17 (3.4) 81 (5.3) 59 (5.0) 3 (2.8) 0 (0.0) 32 (3.2) 192 (4.1)
 Other, male 4 (0.8) 25 (1.6) 82 (7.0) 4 (3.7) 2 (0.6) 10 (1.0) 127 (2.7)
 Other, female 2 (0.4) 4 (0.3) 21 (1.8) 0 (0.0) 0 (0.0) 8 (0.8) 35 (0.7)
Education
 < year 12 71 (14.0) 239 (15.5) 217 (18.5) 17 (15.6) 130 (36.5) 723 (72.3) 1397 (29.8)
 completed year 12 124 (24.5) 315 (20.5) 333 (28.4) 22 (20.2) 55 (15.4) 167 (16.7) 1016 (21.7)
 vocational/some college 192 (37.9) 506 (32.9) 356 (30.3) 19 (17.4) 56 (15.7) 85 (8.5) 1214 (25.9)
 bachelors or higher 120 (23.7) 479 (31.1) 268 (22.8) 51 (46.8) 115 (32.3) 25 (2.5) 1058 (22.6)
HIV History
Mode of infection
 IDU 24 (4.7) 32 (2.1) 3 (0.3) 4 (3.7) 1 (0.3) 0 (0.0) 64 (1.4)
 MSM 302 (59.6) 1179 (76.6) 829 (70.6) 97 (89.0) 148 (41.6) 24 (2.4) 2579 (55.0)
 Heterosexual 145 (28.6) 252 (16.4) 308 (26.2) 5 (4.6) 182 (51.1) 898 (89.8) 1790 (38.2)
 Other/unknowna 36 (7.1) 76 (4.9) 34 (2.9) 3 (2.8) 25 (7.0) 78 (7.8) 252 (5.4)
Years since diagnosis 1.4 1.1 0.5 1.1 0.9 1.6 1.0
 ≤ 0.5 140 (27.6) 406 (26.4) 579 (49.3) 24 (22.0) 143 (40.2) 249 (24.9) 1541 (32.9)
 0.51 - 1.0 78 (15.4) 309 (20.1) 197 (16.8) 25 (22.9) 38 (10.7) 121 (12.1) 768 (16.4)
 1.01 - 3.0 124 (24.5) 436 (28.3) 238 (20.3) 34 (31.2) 89 (25.0) 265 (26.5) 1186 (25.3)
 3.01 - 5.0 66 (13.0) 207 (13.5) 80 (6.8) 11 (10.1) 40 (11.2) 125 (12.5) 529 (11.3)
 > 5.0 99 (19.5) 181 (11.8) 80 (6.8) 15 (13.8) 46 (12.9) 240 (24.0) 661 (14.1)
Hepatitis
Hepatitis B 4 (0.8) 28 (1.9) 20 (1.7) 2 (1.9) 24 (6.8) 52 (5.2) 130 (2.9)
Hepatitis C 43 (8.6) 81 (5.5) 22 (1.9) 5 (4.7) 9 (2.5) 11 (1.1) 171 (3.7)

IDU= injecting drug use; MSM,=men who have sex with men.

a

Other/unknown includes: 0.6% blood products, 1.0% other, 3.8% unknown.